Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Yuguan Biotech Co., Ltd.（delonix Bioworks)

Clinical trials sponsored by Shanghai Yuguan Biotech Co., Ltd.（delonix Bioworks), explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New meningitis b vaccine enters human testing Results expected May 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New meningitis b vaccine enters human testing

Vaccine Recruiting now

This early-stage trial is testing a new vaccine called DX-104 to see if it is safe and triggers an immune response against group B meningococcal bacteria, which can cause meningitis. The study involves 30 healthy adults aged 18 to 50 who will receive either the new vaccine or an …

Phase 1 • Sponsor: Shanghai Yuguan Biotech Co., Ltd.（Delonix Bioworks) • Aim: Vaccine

Last updated Jun 27, 2026 12:04 UTC